F M Investments LLC Invests $3 Million in Astera Labs, Inc. (NASDAQ:ALAB)

F M Investments LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 22,652 shares of the company’s stock, valued at approximately $3,000,000.

Several other institutional investors also recently added to or reduced their stakes in the stock. Whittier Trust Co. of Nevada Inc. bought a new position in shares of Astera Labs during the 4th quarter valued at approximately $25,000. Steward Partners Investment Advisory LLC lifted its stake in Astera Labs by 99.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock valued at $26,000 after purchasing an additional 99 shares during the last quarter. Kestra Investment Management LLC bought a new position in Astera Labs during the fourth quarter valued at $28,000. Geneos Wealth Management Inc. purchased a new stake in Astera Labs in the fourth quarter worth $36,000. Finally, Global Retirement Partners LLC increased its position in Astera Labs by 3,155.6% in the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock worth $39,000 after buying an additional 284 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

NASDAQ ALAB opened at $58.86 on Friday. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $147.39. The company has a fifty day moving average of $74.30 and a 200-day moving average of $90.83. The company has a market capitalization of $9.54 billion and a P/E ratio of -34.02.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. As a group, analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analysts Set New Price Targets

ALAB has been the subject of a number of research reports. Raymond James started coverage on shares of Astera Labs in a research report on Friday, March 14th. They set an “outperform” rating and a $82.00 target price for the company. Craig Hallum lifted their price objective on shares of Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a research note on Tuesday, February 11th. Needham & Company LLC restated a “buy” rating and set a $140.00 target price on shares of Astera Labs in a research report on Tuesday, February 11th. Morgan Stanley reduced their price target on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 28th. Finally, Northland Capmk raised Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. One analyst has rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Astera Labs currently has an average rating of “Buy” and an average price target of $112.77.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Michael E. Hurlston sold 2,500 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $92.08, for a total transaction of $230,200.00. Following the completion of the sale, the director now directly owns 91,794 shares in the company, valued at $8,452,391.52. This represents a 2.65 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, General Counsel Philip Mazzara sold 7,536 shares of Astera Labs stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $92.07, for a total value of $693,839.52. Following the completion of the transaction, the general counsel now owns 241,209 shares in the company, valued at approximately $22,208,112.63. This represents a 3.03 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 633,990 shares of company stock worth $54,235,012 over the last ninety days.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.